Run the TCS London Marathon with the Mikaere Foundation in April 2026

Run the TCS London Marathon and make a difference! One in three children born with NKH won’t see their first birthday. With your help, we e can change this outcome! Conquer this stunning closed road, central London run, one of the big six. This event is a world-renowned marathon that attracts thousands of runners every year.

Date: Sunday 26 April 2026
Registration fee: £100
Location: Pall Mall, London, ‎SW1
Minimum sponsorship: £2000 (excluding gift aid)
Fundraising requirement: At least half of the fundraising goal must be met by January 5th 2026, else you run the risk of losing your place.

Charity Place

Apply for a charity place with the Mikaere Foundation today!

Registration Fee: £100
Fundraising Target: minumum £2000
Date: Sunday 26 April 2026

Already have a place?

If you have a ballot place on the 2026 TCS London Marathon, we’d love to have you on the team!

Join for free, with no minimum fundraising target. We just ask that you raise what you can, so we can keep pushing for a future for children with NKH.

    I have questions

    The Course

    Why we need you

    The Mikaere Foundation needs your support more than ever. By fundraising, you’ll help fund:

    • Groundbreaking research into effective treatment and gene therapy therapy for Nonketotic Hyperglycinemia (NKH) – drastically changing the outcome for children born with NKH.
    • Support services for children and families living with NKH. With NKH comes seizures, dystonia, pain and developmental delay.
    • Outreach to newly diagnosed families, so they have support in their corner, right when they need it.
    • Getting NKH specific information to families, nurses, therapists, carers and doctors.

    could fund special restriction enzymes, used in NKH Research. These work like molecular scissors to cut up the long strands of DNA in our cells. This is vital in helping us learn more about the genetic mutations of NKH.

    could fund a months worth of outreach, providing NKH information to newly diagnosed families right when they need it most.

    could fund a week of a post doc researcher, analysing sample assays, which tell us if NKH gene therapy is working in our models, getting us closer to a cure.

    Scroll to Top